Effects of GS-CA1 on nuclear envelope-associated early HIV-1 infection steps
The novel HIV-1 drugs GS-CA1 and the recently approved lenacapavir (GS-6207) target the viral structural protein capsid (CA). However, their multiple mechanisms of action have not been fully characterized. Here, we investigated the effects of GS-CA1 on the early stages of HIV-1 infection, specifical...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Virology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fviro.2025.1547176/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|